<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-E3PRN9I3</identifier><date>2023</date><creator>Omerzu, Tomaž</creator><relation>documents/doc/E/URN_NBN_SI_doc-E3PRN9I3_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-E3PRN9I3_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 17-21</format><identifier identifier_type="ISSN">0353-3484</identifier><identifier identifier_type="COBISSID_HOST">149833731</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-E3PRN9I3</identifier><language>slv</language><publisher publisher_location="Ljubljana">Medicinski razgledi</publisher><source>Medicinski razgledi (Supplement)</source><rights>InC</rights><subject language_type_id="eng">clinical biomarkers</subject><subject language_type_id="slv">klinični biološki označevalci</subject><subject language_type_id="slv">multipla skleroza</subject><subject language_type_id="eng">multiple sclerosis</subject><subject language_type_id="eng">prognostic factors</subject><subject language_type_id="slv">prognostični dejavniki</subject><title>Uporaba kliničnih bioloških označevalcev pri oblikovanju prognoze bolnikov z multiplo sklerozo</title><title>Use of clinical biomarkers in prognostication of patients with multiple sclerosis</title></Record>